Recent investigations have identified a unique retinal EC population in diabetes alongside a negative feedback regulatory pathway that attenuates endothelial dysfunction by upregulating alkaline ceramidase 2 (ACER2) expression to decrease ceramide content (Yao et al., 2024). This evidence concerns the gene ACER2 and diabetes mellitus.